Outlook Therapeutics Inc (OTLK)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Operating Deficit Improves to $-15.7 Million in Q1 2024 Earnings Season for Biotech & Pharma Firm
Outlook Therapeutics Inc Reveals Significant Operating Losses in Fourth Quarter of 2023
company, reduction in the company performance throughout the most recent fiscal period
Among many entities, the OTLK issued as well its fourth quarter of 2022 numbers